Whereas a cardinal role for b-amyloid protein (Ab) has been postulated as a major trigger of neuronal injury in Alzheimer's disease, the pathogenic mechanism by which Ab deranges nerve cells remains largely elusive. Here we report correlative in vitro and in vivo evidence that an excitotoxic cascade mediates Ab neurotoxicity in the rat magnocellular nucleus basalis (MBN). In vitro application of Ab to astrocytes elicits rapid depolarization of astroglial membranes with a concomitant inhibition of glutamate uptake. In vivo Ab infusion by way of microdialysis in the MBN revealed peak extracellular concentrations of excitatory amino acid neurotransmitters within 20±30 min. Ab-triggered extracellular elevation of excitatory amino acids coincided with a signi®cantly enhanced intracellular accumulation of Ca 2+ in the Ab injection area, as was demonstrated by 45 Ca 2+ autoradiography. In consequence of these acute processes delayed cell death in the MBN and persistent loss of cholinergic ®bre projections to the neocortex appear as early as 3 days following the Ab-induced toxic insult. Such a sequence of Ab toxicity was effectively antagonized by the N-methyl-D-aspartate (NMDA) receptor ligand dizocilpine maleate (MK-801). Moreover, Ab toxicity in the MBN decreases with advancing age that may be associated with the age-related loss of NMDA receptor expression in rats. In summary, the present results indicate that Ab compromises neurons of the rat MBN via an excitotoxic pathway including astroglial depolarization, extracellular glutamate accumulation, NMDA receptor activation and an intracellular Ca 2+ overload leading to cell death.
Introduction
One of the neuropathological hallmarks of Alzheimer's disease (AD) is the accumulation of b-amyloid peptides (Ab) in regions of the cerebral cortex and hippocampus that are essential for information processing (Glenner & Wong, 1984; Selkoe, 1991; Harkany et al. 2000) . Ab is the g-secretase cleavage product of the amyloid precursor protein (APP; Checler, 1995; Selkoe, 1991; Haass et al., 1992) and in its mature form consists of 42 amino acid residues (Ab (1±42) ; Glenner & Wong, 1984) . Noxious conditions, such as in¯ammation (Yan et al., 1996) , metabolic disturbances (Hall et al., 1995) and excitotoxic stimulation , selectively alter processing of APP, modify intracellular Ab catabolism (Iwata et al. 2000) and result in the enhanced generation of full-length Ab. Ample experimental evidence indicates that Ab affects neural functions in a bi-modal manner (Yankner et al., 1990) . Whereas picomolar Ab concentrations promote neural development (Mattson, 1997) and modulate cholinergic neurotransmission (Auld et al., 1998) , higher concentrations of Ab are a challenge to the viability of nerve cells (Yankner et al., 1990; Mattson et al., 1992) . Neurotoxic Ab alone or in conjunction with glutamate orchestrates a variety of distinct intracellular toxic events with an initial rapid elevation of the intracellular free Ca 2+ concentration ([Ca 2+ ] i ; Mattson et al., 1992; Suo et al., 1997; Stix & Reiser, 1998) accompanied by sustained dysregulation of various aspects of [Ca 2+ ] i homeostasis (Mattson, 1997) . Dysbalance of [Ca 2+ ] i impairs the mitochondrial terminal oxidation (Lafon-Cazal et al., 1993) resulting in excessive generation of reactive oxygen species (ROS; Behl et al., 1994; Mark et al., 1997; Suo et al., 1997 ). It appears that Ca 2+ -and ROS-mediated toxic mechanisms following Ab (1±42) exposure exert a cumulative challenge to nerve cells in vivo (Harkany et al., 1999a; Suo et al., 1997) , although the exact time-constants, interactions and sequence of the toxic cascade remain largely unclear.
Direct neurotoxicity of Ab fragments in the brain was studied in a number of animal models (Abe et al., 1994; Flood et al., 1994; Giovannelli et al., 1995; Harkany et al., 1995a Harkany et al., ,b, 1998 1999a,b) . In fact, loss of cholinergic basal forebrain neurons was demonstrated after local intraparenchymal application of Ab fragments (Giovannelli et al., 1995; Harkany et al., 1995b Harkany et al., , 1998 , whilst the presence of local Ca 2+ -binding proteins, and pharmacological blockade of N-Methyl-D-Aspartate (NMDA) receptors were unveiled as factors that may rescue cholinergic neurons from Ab toxicity (Harkany et al., 1995a; O'Mahony et al., 1998; 1999b) .
In the present report an attempt was made to provide correlative in vitro and in vivo evidence on the sequence of cellular events that mediate acute Ab (1±42) toxicity. To monitor cellular consequences of Ab toxicity, Ab (1±42) and Ab (25±35) were applied to cholinergic projection neurons of the rat magnocellular nucleus basalis (MBN) as a neuronal model structure that allows correlative behavioural and neuroanatomical evaluation of neuronal injury. It is to be emphasized that Ab-induced lesions of the rat MBN mimic acute neuronal injury (Harkany et al., 1999a; Stuiver et al., 1996) and thereby model initial steps of neurotoxic signalling that may turn to pathological dimensions in AD. Moreover, the age-dependent involvement of NMDA receptors in Ab toxicity and the potential therapeutic role of their neuropharmacological modulation are discussed.
Materials and methods

Peptide synthesis
Ab (1±42) and Ab (25±35) were synthesized with amide at the C-terminal by a solid phase technique involving t-butoxycarbonyl (Boc) chemistry as described previously (Harkany et al., 1995a; Laskay et al., 1997; 1999b) . In brief, both peptides were synthesized on an ABI 430A automated peptide synthesizer and peptide chains were elongated on para-methylbenzhydrylamine (MBHA) resin (0.57 mmol/g). Couplings were performed with dicyclohexylcarbodiimide with the exception of Asn and Gln, which were incorporated with N-hydroxybenzotriazole ester to avoid side reactions. Final deprotection and cleavage of the peptides from the resin were carried out with hydrogen¯uoride (HF) at 0°C for 60 min. Subsequently, free peptides were precipitated, solubilized, ®ltered and lyophilized. Crude peptides were puri®ed by using a Shimadzu LC-8A highperformance liquid chromatography (HPLC) system equipped with a Backbond WP C 4 column. In both cases, amino acid analyses demonstrated the expected amino acid composition and electrospray mass spectrometry (ES-MS) con®rmed the expected molecular masses.
Fluorescent determination of astroglial membrane potential
Primary rat astrocyte cultures were prepared as described previously (Laskay et al., 1997) . Brie¯y, astrocytes were prepared by mechanical dissociation from hemispheres of new-born rats which had been decapitated, then plated onto poly-L-ornithin and ®bronectin-coated glass coverslips, placed on 12-well culture dishes and cultured in Dulbecco's modi®ed Eagle's medium containing 10% heat-inactivated fetal calf serum (Sigma), supplemented with 4500 mg/L glucose for 4±6 weeks at 37°C in humidi®ed 5% CO 2 atmosphere. At this stage, approximately 95% of the cells exhibited glial ®brillary acidic protein immunoreactivity, whilst eventually no microglia were present in the cultures. Astroglial cells on coverslips were exposed to 1 mM ®nal concentration of Ab (1±42) for 8 h. Astrocytes were then washed with HEPES-buffered Tyrode solution containing 1.8 mM CaCl 2 (HBT, pH = 7.4). Subsequently, the cells were labelled with 100 nM of the voltage-sensitive¯uorescent cationic probe 3,3¢-dipropyl-thiacarbocyanine iodide (DiS-C 3 (3); gift of Dr J. Plasek) for 20 min at 37°C. Membrane depolarization of astroglial cells elicits a drop in DiS-C 3 (3)¯uorescence intensity (Plasek et al., 1994) . Astrocyte-coated coverslips were then transferred to quartz cuvettes (1 3 1 cm diameter) containing HBT at 25°C. Steady-state¯uores-cence intensities were determined using 550 and 580-nm excitation and emission wavelengths, respectively. Mean¯uorescence intensity of unlabelled cells was 136 6 44. Protein contents of the samples were determined according to the method of Lowry et al. (1951) using bovine serum albumin as standard.
Glutamate uptake
Effects of Ab (25±35) on astroglial glutamate uptake were measured by using L-[G-3 H]glutamate (Amersham, 49 Ci/mmol speci®c activity; Parpura-Gill et al., 1997) on primary astrocyte cultures prepared from hemispheres of rat embryos (day 17) by trypsine-induced dissociation, and plated onto poly-L-lysine-coated glass coverslips. Astrocytes were cultured in the presence of Ab (25±35) (100 mM) for 24 h, whilst nontreated glial cultures served as controls. Subsequently, cells were transferred to Ca 2+ /Mg 2+ -containing Hanks' solution for 30 min at 37°C. The incubation medium was then replaced with 500 mL Hanks' solution to which 2, 5, 10, 15, 25, 50, 100 or 300 mM glutamate had been added containing < 0.1% L- [G- 3 H]glutamate (with a ®nal activity of 0.05 mCi/mL) and incubated for 12 min. Glutamate uptake was stopped by three washes with icecold Hanks' solution and the cells were lysed in 600 mL of 0.1 M NaOH overnight at 4°C. Thereafter, 400 mL of cell lysates were resuspended and mixed with 2.6 mL Optiphase scintillation cocktail (Sigma) which was used for determination of radioactivity by a liquid scintillation counter (LKB Rakbeta). Protein concentrations of the samples were determined according to a standard protocol (Lowry et al., 1951) . Glutamate uptake was expressed as pmol glutamate/min/ mg protein. Each data point represents the result of at least four independent measurements.
Animals, acute lesion procedure and MK-801 administration
Young adult (3 months of age, n = 50) and senescent (28 months of age, n = 22) male Wistar rats (n = 72) were housed individually at least 3 days prior to the start of the experiments and kept on a normal laboratory diet ad libitum in an air-controlled room (21 6 2°C) with a 12-h light/dark cycle (lights on at 08.00 h). The animals were anaesthetized with halothane (1.5%, 1.8 L/min air¯ow), and their heads were mounted in a stereotaxic frame (Narishige, Japan). All efforts were made to prevent/minimize animal suffering throughout the experiments. Their care and treatment were in accordance with the European Communities Council Directive (86/609/EEC) and approved by the Ethical Committee of the University of Groningen (DEC #2286). For 45 Ca 2+ autoradiography and for standard histochemical experiments, 1 mL of 200 mM Ab (1±42) or Ab (25±35) was injected slowly (0.1 mL/min) into the right MBN (AP 1.5 mm, lateral 3.2 mm, ventral 7.0 and 6.2 mm [0.5 mL at both co-ordinates]; Paxinos & Watson, 1986 ) with a Hamilton microsyringe. Aliquots of both Ab (1±42) and Ab (25±35) were freshly dissolved in ultrapure water. To elicit extensive excitotoxic lesions in the MBN, NMDA (60 mM; Sigma) was infused under identical conditions and co-ordinates into the rat brain in a total volume of 1 mL. NMDA was dissolved in 0.01 M phosphate-buffered saline (PBS, pH = 7.4). As previous studies did not demonstrate signi®cant toxicity of scrambled or reversed Ab sequences (Kowall et al., 1992; Geula et al., 1998) , animals injected only with vehicle solution served as sham-controls throughout the experiments (Harkany et al., 1995a,b; 1999b) . Both Ab (1±42) and NMDA decrease the pH of the vehicle solution. Therefore, an additional control study was performed by injecting pH-equivalent PBS (pH = 4.0) into the MBN. Quantitative analysis of cortical cholinergic innervation revealed increased acetylcholinester-ase (EC 3.1.1.7) (AChE)-positive ®bre loss [12.87 6 2.75% (pH = 4.0) vs. 4.69 6 2.41% (pH = 7.4)] which was signi®cantly different from both Ab (1±42) -and NMDA-induced ®bre damage (Fig. 4A) . In all experiments a 14-day survival period was used, based on previous observations (Harkany et al., 1995b; Stuiver et al., 1996; 1999b International, Natick, MA, USA) was dissolved in physiological saline and administered intraperitoneally (i.p.) at a concentration of 5.0 mg/kg body weight in a total volume of 1 mL/kg body weight. This dose was previously determined to effectively antagonize excitotoxic damage of cholinergic projection neurons in the MBN (Harkany et al., 1999b; Stuiver et al., 1996) . MK-801 was applied acutely 1 h prior to Ab (1±42) infusion into the MBN based on previous experience (Stuiver et al., 1996; Harkany et al., 1999b) .
Microdialysis and amino acid analysis
A concentric microdialysis probe made of Travenol hollow ®bers (2 mm diffusion length, 0.2 mm in diameter, 50 kDa mol. wt cutoff) was implanted into the MBN in separate groups of animals at standard co-ordinates (AP 1.5 mm, lateral 3.2 mm, ventral 6.5 mm; Paxinos & Watson, 1986 ) under halothane anaesthesia (1.5%, 1.8 L/ min¯ow rate). The microdialysis probe was then secured to the skull by dental acrylic. Inlet and outlet tubes of the probe were run through a liquid swivel to allow collecting dialysis samples from freely moving conscious animals. Dialysis was started 24 h after probe implantation. Arti®cial cerebrospinal¯uid (ACSF; in mM: Na + , 147; K + , 3.5; Ca 2+ , 2; Mg 2+ , 1; pH = 7.1) served as vehicle throughout the experiments. Ab (1±42) was used in a 200-mM concentration and solubilized in ACSF to which 0.1% tri¯uoroacetic acid (TFA) had been added. Vehicle + TFA-dialysed animals served as controls. Following a 30-min equilibration period, Ab (1±42) was dialysed for 100 min. A 2-mL/min steady-state¯ow rate was used throughout. Out¯ow fractions were collected in 10-min blocks to determine excitatory action of Ab (1±42) . Baseline of the dialysis was calculated as the average of three baseline measures. Extracellular excitatory amino acid (EAA) concentrations were determined after precolumn derivatization by isocratic HPLC analysis of ortho-phtalaldehyde (OPA) derivatives of EAAs as previously described (Timmerman & Westerink, 1997) . The derivatizing reagent was added separately to the microdialysis samples, mixed for 5 s and immediately loaded into the 50-mL sample loop of an HPLC valve and onto the column. Furthermore, a second loop of 300 mL was continuously ®lled with 90% ethanol and directly after the g-aminobutyric acid (GABA) peak was recorded the loop content was injected onto the column to quickly remove all subsequent peaks. The HPLC system consisted of an LKB 2150 HPLC pump (Pharmacia, Peapack, NJ, USA), an S3 ODS2 Spherisorb column with 3-mm particle size, Rheodyne valves and a¯uorimeter (Shimadzu RF-10A, Hertogenbosch, The Netherlands). Fluorimetric detection was performed at 340-nm extinction and 400-nm emission wavelengths. A mobile phase consisting of 0.05 mol/L Na 2 PO 4 , 0.01 mmol/L Na 2 -EDTA, 0.6% (v/v) tetrahydrofuran and 30% (v/v) methanol (pH 6.8 adjusted with phosphoric acid) was used. The derivatization reagent was prepared as follows: 5 mg OPA (Sigma) was dissolved in 50 mL methanol and added to 5 mL 0.5 mol/L NaHCO 3 (pH adjusted to 9.5 with NaOH) containing 15 mL 2-mercaptoethanol. The reagent was prepared daily. Aspartate, glutamate and taurine were appropriately separated. Ab ®ltration through the probe was checked in vitro by measurement of the concentration difference between in¯ow and out¯ow [ 1 3 H]Ab (25±35) contents of perfusates (at a 200-mM in¯ow concentration) by using a liquid scintillation counter.
Home cage-like activity
Microdialysed animals were caged individually 4 days prior to probe implantation. Microdialysis of freely moving animals was carried out in their home cages in a noise-sealed room. The experiment started at 10.00 h, during the daily inactive phase of the animals. Although connection of the microdialysis setup to the implanted probe resulted in a brief transient mobility increase of the rats, their activity returned to baseline immobility during the 30-min probe equilibration period. Representative changes in spontaneous behaviours were recorded for 5 min at every 15 min throughout Ab (1±42) infusion. During the observation intervals, spontaneous activities such as rearing, snif®ng, walking, grooming, eating and immobility were determined in every 10 s (Harkany et al., 1999b) . Thereafter, representative scores of the active components were summed up in 5-min blocks and analysed statistically.
In vivo
45 Ca 2+ autoradiography
Sixty minutes following Ab (1±42) or NMDA infusion into the MBN, 100 mCi of 45 CaCl 2 tracer (speci®c activity 0.6 Ci/mmol, Amersham)
was administered intravenously in a total volume of 500 mL physiological saline (Stevens et al., 1998) . Twenty-four hours after 45 CaCl 2 administration the animals were killed by decapitation under ether anaesthesia. Whole brains were rapidly removed from the skull and immediately frozen, and 20-mm thick coronal sections were cut on a cryostat microtome. Brain slices were thaw-mounted onto gelatine-coated glass slides and dried for 24 h at room temperature in the presence of silica gel. Thereafter, dried sections were exposed to Kodak B-max Hyper®lm at 4°C for 14 days which was then developed with D19 Kodak developer.
Quantitative histochemistry
Fixation of the brains was carried out under deep 6% Napentobarbital (Sigma) anaesthesia by transcardial perfusion with 400 mL ®xative composed of 4% paraformaldehyde in 0.1 M PB, which was preceded by a short prerinse with physiological saline. Brains were post®xed for 4 h in the same ®xative and cryoprotected by overnight storage in 30% sucrose in 0.1 M PB at 4°C. Thereafter, coronal frozen sections were cut on a cryostat microtome at a thickness of 20 mm. Sections of Ab (1±42) -lesioned and sham-operated animals were processed simultaneously; the brains of sham-operated rats were marked by punching a needle hole in the caudate putamen. Histochemical localization of deposited Ab (1±42) was carried out by means of a standard histochemical protocol using thio¯avine-S uorescence detection . Brie¯y, premounted sections were incubated in 1 : 1 dilution of chloroform and ethanol for 1 h, rehydrated in a descending ethanol gradient and stained in a 0.1% solution of thio¯avine-S (Sigma) for 10 min. Thereafter, stained sections were differentiated in 80% ethanol and covered with Immumount (Shandon, Shandon Holland, The Netherlands). The distribution of thio¯avine-S-labelled Ab (1±42) deposits in the MBN was analysed by a Leitz Ortholux II (Leica)¯uorescence microscope. For AChE histochemistry, free-¯oating sections were post®xed by immersion in a 2.5% glutardialdehyde solution in 0.01 M PB saline (pH = 7.4) overnight at 4°C. Cholinergic ®bres were visualized by staining for AChE according to Hedreen et al. (1985) using a silver nitrate intensi®cation procedure.
Mechanism of b-amyloid toxicity in rat MBN 2737 AChE ®bre density was measured in layer V of the posterior somatosensory cortex according to a standard protocol by using a Quantimet Q-600 HR computerized image analysis system (Leica). Surface area density of cortical AChEpositive ®bres [(area covered by AChE-positive cholinergic ®bres)/ (total sampling area), given as a percentage] was measured in two parietal cortical sections (at co-ordinates ±1.3 mm and ±1.7 mm; Paxinos & Watson, 1986) , representing the densest cholinergic innervation from the damaged MBN division (Luiten et al., 1995; Stuiver et al., 1996) . After background subtraction and grey-scale threshold determination, the surface area of skeletonized AChEpositive ®bers was computed in each parietal cortical section by using a 599.4-nm emission ®lter. The relative value of ®bre reduction was calculated in pre-established quadrants as the difference between the surface area density at lesioned and contralateral sides of the brain.
Data analysis and statistics
Result on in vitro biochemical parameters, extracellular concentrations of amino acids (AAs) (between experimental groups) as well as the loss of AChE-positive ®bres were statistically evaluated with oneway analysis of variance (ANOVA) followed by the Student±Newman± Keuls post hoc test (SPSS for Windows, Release 9.0). Timedependent alterations of extracellular AAs within single experimental groups were evaluated by repeated-measures ANOVA. Behavioural changes were analysed by the nonparametric Mann±Whitney U-test. A P level of < 0.05 was taken as indicative of statistical signi®cance for the tests. Data on biochemical and histochemical parameters were expressed as means 6 SEM whilst data on home-cage-like behaviour was presented as medians.
Results
Inhibition of astroglial glutamate uptake by Ab
Primary cultures of astrocytes were used to determine the effects of Ab (1±42) and Ab (25±35) exposure on homeostasis-maintaining functions of glial cells. Whilst long-term Ab (25±35) treatment is known to produce extensive inhibition of astroglial glutamate uptake in vitro (Parpura-Gill et al., 1997), we were particularly interested in the acute changes of glial membrane functions and glutamate uptake, which alterations can be implicated in an in vivo reconstruction of a Ab (1±42) -induced neurotoxic cascade. Astroglial membrane depolarization was determined after incubation of the astrocytes with Ab (1±42) in the presence of the¯uorescent potential-sensitive cationic dye DiS-C 3 (3) and expressed as the decrease of DiS-C 3 (3) uorescence intensity (Fig. 1A) . A signi®cant reduction of thē uorescence intensity of Ab (1±42) -treated astroglia cultures was revealed. Taking the¯uorescence signalling characteristics of DiS-C 3 3 into consideration (Plasek et al., 1994) , such a 20.72 6 3.77% decline in¯uorescence intensity after incubation with 1 mM Ab (1±42) for 8 h indicates sustained membrane depolarization (Fig. 1A) .
As depolarization of astrocyte membranes was previously claimed to directly abate glutamate transporter function (Ramaharobandro et al., 1982) , the action of Ab (25±35) on glutamate uptake was assayed employing radiochemical determination of L-[G- 3 H]glutamate uptake (Fig. 1B) . Exposure of astrocytes to the active fragment of Ab (25±35) (100 mM, 24 h incubation period) signi®cantly and concentrationdependently displaced the uptake of L-[G-3 H]glutamate from the culture medium in a broad spectrum of glutamate concentrations ranging from 25 to 300 mM. Independent from the presence of Ab (25±35) , glutamate uptake of both treated and control cultures exhibited a saturating pro®le (control: y = 1.9283 * ln(x) ± 1.0587, r 2 = 0.9397; Ab (25±35) : y = 1.0585 * ln(x) + 0.0446, r 2 = 0.9082).
Similar to previous in vitro ®ndings on hippocampal astrocytes (Harris et al., 1996) , exposure of primary astroglial cells to Ab (25±35) elicited an abrupt 39.27% slope in the kinetics of glutamate uptake (Fig. 1B) ) ] mM). It is worth noting that the rationale behind using Ab (25±35) instead of Ab (1±42) was two-fold. First, we wanted to ensure the reproducibility and comparability of our studies with those of Parpura-Gill et al. (1997) who showed a decline of glutamate uptake after 7 days of incubation with Ab (25±35) . Second, Ab (1±42) by its signi®cantly greater propensity to form aggregates in aqueous solution (e.g. culture media), relative to that of Ab (25±35) , can lead to a higher variability that in¯uences the glutamate uptake measurement in vitro.
Temporal pro®les of excitatory amino acid neurotransmitters in the MBN following Ab infusion
The inhibition of astroglial glutamate uptake by Ab in conjunction with previous in vitro observations on a rapid appearance of a brusque Ca 2+ in¯ux into both neurons Morimoto et al., 1998; Harkany et al. 2000) and glial cells (Harris et al., 1996; Stix & Reiser, 1998 ) after exposure to Ab fragments suggest an excitotoxic nature for this peptide. However, in vivo evidence is still lacking as to whether Ab (1±42) in the brain compromises neurons via a similar excitotoxic mechanism. To study the local, acute-phase effects of Ab (1±42) infusion in the brain, we utilized microdialysis in conscious freely moving animals that allows on-line monitoring of extracellular amino acid levels in response to continuous infusion of Ab (1±42) . The microdialysis probe was implanted into the right intermediate MBN of rats, inasmuch as it consists of the group of magnocellular cholinergic neurons which were previously demonstrated to be particularly vulnerable to neurotoxic insults (Harkany et al., 1995b Luiten et al., 1995; Stuiver et al., 1996; 1999b) . To achieve an ef®cient penetration of Ab (1±42) through the membrane of the microdialysis probe a speci®c solvent, composed of ACSF containing 0.1% TFA, was used, which counteracted the¯eet aggregation of Ab (1±42) in the microdialysis probe or in its tubing. Omission of TFA resulted in increased aggregation of [ 1 3 H]Ab (25±35) with a signi®cant decrease of in vitro peptide recovery (< 1%). Such an attempt to maintain Ab (1±42) in a partially dissolved form, however, led to a decrease of the pH value of ACSF from its original (pH = 7.1) to pH » 2±3. Therefore, control data were obtained by microdialysis of an identical pH-equivalent ACSF + TFA vehicle ( Fig. 2A) .
Infusion of Ab (1±42) into the MBN induced a signi®cant and sustained increase in the extracellular concentrations of the major excitatory AA (EAA) neurotransmitters, aspartate and glutamate ( Fig. 2A) . Extracellular elevation of the EAAs reached its maximum within 20 min following the start of Ab (1±42) microdialysis. A speci®c maximal increase of 114.02 6 10.81% and 104.20 6 19.36% was recorded for aspartate and glutamate, respectively, compared to EAA concentration in the vehicleperfused control group at 20 min. Whilst a continuously raised extracellular EAA concentration was recorded up to 50 min of Ab (1±42) dialysis, both aspartate and glutamate levels exhibited decrementing pro®les in later phases of the infusion period. As taurine release may occur concomitantly with that of glutamate (Pazdernik et al., 1992) , changes in its extracellular contents were also determined. Markedly increased extracellular taurine levels were demonstrated throughout the 10±80-min period of Ab (1±42) microdialysis. These reached a maximum at 30 min with a speci®c value of 186.62 6 17.84% of the corresponding control level. Nevertheless, a brief elevation of both extracellular glutamate and taurine levels was recorded at 20 min of vehicle dialysis that might be attributed to the infusion of the vehicle solution at a largely nonphysiological pH value.
Ab (1±42) penetration through the probe was determined by in vitro dialysis of [ 1 3 H]Ab (25±35) yielding a 6.88% peptide utilization. Because Ab (1±42) was dialysed over a 100-min period, the quantity of Ab (1±42) deposited in the brain, as extrapolated from the in vitro recovery of [ 1 3 H]Ab (25±35) , may be considered to be equal to the effects of an equimolar acute injection of 2.75 nmol Ab (1±42) .
The MBN is known as the origin of the cholinergic modulatory input to the entire neocortex and thus functionally modulates cortexassociated behavioural and learning and memory functions (Van der Zee et al., 1994; Harkany et al., 1998) . It was previously demonstrated that Ab (1±42) -induced lesions to the MBN evoke apparent impairments both in the spontaneous activity and in the learning performance of rats 1999b) . Hence, home cagelike activity of freely moving animals was recorded throughout microdialysis to determine the behavioural outcome of continuous Ab (1±42) infusion. Apart from a brief activity increase at 15 min after the start of microdialysis, sham-control animals remained immobile throughout the entire experimental period. Such an initial activity change may be attributed to a slight excitatory effect of the vehicle solution. In turn, Ab (1±42) -administered rats exhibited an increased pattern of mobility from 60 min on with horizontal ambulation as the most frequent behavioural parameter (Fig. 2B) .
Thio¯avine-S histochemistry revealed the formation of Ab (1±42) deposits in brain parenchyma surrounding the implanted microdialysis probe (Fig. 2C) . Ab (1±42) deposits were similar in appearance to those resulting from acute Ab (1±42) lesions in the MBN (O'Mahony et al., 1998). The vast majority of Ab (1±42) was visualized in the close proximity of the dialysis membrane, virtually within a distance of 200±250 mm, and a dense Ab (1±42) -positive rim encircled a clear border zone in the brain (Fig. 2C) (Fig. 3C) . The extent of 45 Ca 2+ labelling in the MBN may also indicate limited diffusion of Ab (1±42) in vivo and accumulation of the peptide in the close vicinity of the injection without deep penetration into the brain parenchyma (Fig. 3A) . Acute injection of NMDA induced a similar local increase in [ 45 Ca 2+ ] i (Fig. 3B) . In fact, the extent of the surface area exhibiting 45 Ca 2+ accumulation was signi®cantly increased following NMDA lesions, compared to the effects of Ab (1±42) infusion, which can be attributed to a considerably greater diffusion probability of the glutamate analogue in the brain.
Time-course of Ab neurotoxicity and in vivo neuroprotection by dizocilpine maleate
Acute phase changes appear within minutes to hours following Ab (1± 42) application. As the result of such an acute Ca 2+ -mediated cytotoxic pathway neuronal loss may occur in the MBN. To establish the time-course and the extent of cholinergic cell death following in vivo application of Ab (1±42) and Ab (25±35) , the peptides were unilaterally injected into the MBN (Fig. 4A) . To verify our hypothesis on the involvement of NMDA receptor-mediated Ca 2+ entry as trigger of Ab toxicity, MK-801 was administered (i.p.) 1 h prior to the infusion of Ab (1±42) (Fig. 4B and C) . Because the expression of NMDA receptors declines with ascending age (Magnusson & Cotman, 1993; Mitchell & Anderson, 1998) , we further anticipated an age-dependent modulation of Ab toxicity. Hence, Ab (1±42) was injected into the MBN of senescent (28 months of age) rats (Fig. 4D) .
Cholinotoxic effects of both Ab (25±35) and Ab (1±42) , as indicated by the loss of AChE-positive neurites in the somatosensory cortex, became apparent as early as 3 days postsurgery (Fig. 4A) . Whereas Ab (25±35) toxicity exhibited a gradual decline (day 3, 20.65 6 4.5%; day 14, 12.35 6 2.9%), Ab (1±42) -induced loss of cholinergic projections irreversibly persisted throughout the survival periods examined (day 3: 23.69 6 2.8%; day 14: 21.53 6 3.9%). Similar to the neuroprotective ef®cacy of chronic NMDA receptor blockade , acute application of the NMDA receptor antagonist MK-801 1 h prior to Ab (1±42) infusion signi®cantly attenuated Ab (1±42) toxicity, as was indicated by the preservation of cholinergic projection ®bers (day 14: 21.53 6 3.3% [Ab (1±42) ] vs. (Fig. 4B and C ). Histochemical data demonstrate that in parallel with the extensive disappearance of AChE-positive projections the staining intensity of resistant AChEpositive cholinergic/cholinoceptive elements also considerably decreased following Ab (1±42) infusion (Fig. 4B) (1±42) and (b) its effects on spontaneous behaviour. Extracellular levels of both aspartate and glutamate exhibited rapid increases and reached peak concentrations 20 min after the start of Ab (1±42) infusion followed by gradually decrementing amino acid pro®les in later phases of the study. Additionally, Ab (1±42) induced sustained enhancement of taurine release with peak values at 50 min. (b) Determination of home cage-like activity during in vivo microdialysis revealed that infusion of ACSF induced an early transient activation of sham-control animals, whilst Ab (1±42) infusion elicited a delayed behavioural activation between 60 and 90 min after the start of Ab (1±42) dialysis. (c) Ab (1±42) infusion into the MBN resulted in the formation of intraparenchymal Ab (1±42) deposits. Dark-®eld photomicrograph in (c) depicts Ab (1±42) accumulation surrounding the probe membrane (arrows) with an apparently limited, delineated diffusion pattern. Six Ab (1±42) -dialysed and four control rats were used in the study. Asterisk denotes the placement of the microdialysis probe. Scale bar, 100 mm.
Discussion
Our data demonstrate that infusion of Ab (1±42) or its neurotoxic fragment Ab (25±35) into the rat MBN initiates a complex neurotoxic cascade that affects both glial and neuronal functions. Ab (1±42) hypopolarizes the membranes of astroglial cells and thereby inhibits the uptake of glutamate (Harris et al., 1996; Parpura-Gill et al., 1997) . Such a metabolic arrest elicits extracellular accumulation of EAA neurotransmitters, which under chronic conditions may turn to pathological dimensions. Subsequently, binding of glutamate to its receptors generates a sustained inward Ca 2+ current that is secondarily followed by a Ca 2+ in¯ux through voltage-dependent Ca 2+ channels potentially leading to overt excitation of neurons. Concomitantly, [Ca 2+ ] i undergoes a progressive rise which impels the degeneration of neurons.
The exact molecular interaction of Ab with integral cell-membrane components, such as receptor-like binding sites and lipid components, and the subsequent coupling of signal transduction molecules, is still largely to be ascertained. Besides the association of lypophilic Ab to membrane surfaces (Mattson, 1998) , and formation of Ca 2+ -selective Ab transmembrane pores (Arispe et al., 1996) , recent ®ndings indicate a number of neurotransmitter receptors that may bind Ab in a concentration-dependent manner. Ab was demonstrated to modulate acetylcholine (ACh) release, choline-acetyltransferase activity and [ACh] i in a ligand-like fashion without apparent signs of neurotoxicity in pM to nM concentrations (Kar et al., 1996; Auld et al., 1998) . In fact, binding of Ab to the low-af®nity neurotrophin receptor (p75 NTR ; Kuner et al., 1998) , which is abundantly expressed on cholinergic basal forebrain neurons (Heckers et al., 1994; Ha Èrtig et al., 1998) , may account for the neuromodulatory action of Ab. On the other hand, mM concentrations of oligomer±proto®brillar Ab aggregates act as potent neurotoxins both in vitro (Mattson et al., 1992; Pike et al., 1993) and in vivo (Abe et al., 1994; Giovannelli et al., 1995; Harkany et al., 1995a,b) , probably through trypsinesensitive speci®c binding sites (Lambert et al., 1998) . To investigate the toxic effect of Ab (1±42) on cholinergic MBN neurons, 200 mM freshly dissolved Ab (1±42) , corresponding to 0.2 nmol and 2.75 nmol ®nal quantities of Ab as acute injections or microdialysis infusion, respectively, was administered in the MBN. Previous studies by means of FT-IR spectroscopy revealed that 200 mM Ab forms an array of oligomer Ab species with different molecular weights (LeVine, 1993; Szabo Â et al., 1999) , which may account for the toxic properties of Ab in aqueous solution (Lambert et al., 1998) . We assume therefore that Ab (1±42) in 200 mM concentration undergoes highly ordered aggregation upon local infusion in the rat MBN, which may eventually increase the neurotoxic potential of the peptide (Pike et al., (Paxinos & Watson, 1986) . Scale bar, 1.4 mm.
1993; Harkany et al. 2000) . Thereafter, aggregating Ab species may attack neurons and lead to the depletion of cholinergic parameters in the somatosensory cortex (Harkany et al., 1995b) .
Ample in vitro experimental evidence indicates that Ab may also affect neuronal functions indirectly, by its binding to cell-surface receptors on glial cells (El Khoury et al., 1996; Yan et al., 1996) . Abinduced activation of microglia evokes the release of cytotoxic in¯ammatory cytokines like interleukin-1, -6 and tumour necrosis factor-a (for review see Harkany et al. 2000) , which in turn compromise astroglial functions and elicit neuronal apoptosis. (1±42) toxicity to cholinergic projection neurons of the MBN decreases with advancing age, as was revealed by comparison of Ab (1±42) toxicity in 3-month (young, n = 11) and 28-month (aged, n = 11)-old animals. Data are presented as means 6 SEM. Horizontal bars in (b) denote the cortical layer, which was subjected to quantitative determination of the surface area density of AChE-positive structural elements. Scale bar, 120 mm.
Major characteristics of hampered astroglial function involve a decline of the activity of glutamate transporters (Harris et al., 1996) . Decreased uptake of extracellular glutamate in response to exposure to Ab may yield signi®cantly elevated extracellular glutamate concentrations that may subsequently act as a key trigger of excitotoxic neuronal damage.
In conclusion, the Ab-induced neurotoxic cascade may be generated (a) directly by a ligand-like interaction of Ab (1±42) with excitatory amino acid receptors, such as the NMDA receptor channel, and/or (b) indirectly by the inhibition of glial glutamate uptake leading to the accumulation of glutamate in the extracellular space. However, it is as yet not clear whether Ab (1±42) compromises neurons exclusively by its action via glutamate excitotoxicity or, by itself, as a ligand to membrane-associated mechanisms, directly initiates a toxic signalling pathway involving a substantially enhanced intracellular Ca 2+ entry, exhaustion of intracellular Ca 2+ pools and their inability to sequester Ca 2+ that may act as a`death signal' in neurons Mattson, 1997; Verkhratsky & Petersen, 1998) . Microdialysis infusion of Ab supports the latter theory, as it elicited a rapid and transient extracellular increase of EAA neurotransmitters with peak values at 20±30 and at 50 min that returned to the baseline level 100 min after the start of Ab infusion. A plausible explanation for the two peaks in the dialysis pro®le comes from the assumption that Ab may simultaneously hamper neuronal and astroglial function via distinct mechanisms (e.g. receptor-mediated neuronal excitation, inhibition of glial glutamate transporters) with different time constants. Moreover, the short duration of the extracellular accumulation of EAA may indicate that a glutamate-activated excitotoxic cascade may act as a primary trigger of a complex pathway that renders neurons vulnerable to secondary attacks, and glutamate-and Ca 2+ -independent mechanisms participate substantially in later phases of Ab toxicity.
Although insuf®cient to account for recently suggested peptidic ligand-like characteristics of Ab (Lambert et al., 1998) , such a notion is favoured by the selective displacement of MK-801 binding from regulatory sites of the NMDA receptor by Ab (Cowburn et al., 1994 (Cowburn et al., , 1997 and the exceptional ef®cacy of NMDA receptor antagonists in ameliorating Ab toxicity in vivo (Morimoto et al., 1998; O'Mahony et al., 1998; Harkany et al., 1999b) . Supportive to the proposed role of NMDA receptors in Ab (1±42) toxicity (Cowburn et al., 1997; Mattson et al., 1993; Harkany et al., 1999a) , the spontaneous behavioural activation of Ab (1±42) -dialysed animals may well be a measure of glutamate-mediated excitation of cholinergic projection neurons, as its time delay correlates with that of a persistent Ca 2+ overload following NMDA receptor stimulation in vitro (Randall & Thayer, 1992) . Hence, the behavioural dysfunction is probably associated with a transient acetylcholine release in the neocortex. Furthermore, the noncompetitive NMDA receptor antagonist MK-801 abolished Ab (1±42) cholinotoxicity with high ef®cacy. Our recent pharmacological data therefore concur with previous ®ndings (Harkany et al., 1995b ) that allude to the importance of local Ca 2+ -buffering mechanisms in neuronal survival and rescue from Ab (1±42) excitotoxicity.
Although contradictory data have been reported on the agedependent expression of NMDA receptors in the brain (Magnusson & Cotman, 1993; Shimada et al., 1997; Mitchell & Anderson, 1998) , recent ®ndings of Mitchell & Anderson (1998) provided evidence on the age-dependent selective decline of NMDA receptor expression in the basal forebrain, hippocampus and neocortex. In accordance with the possible involvement of NMDA receptor stimulation in Ab (1±42) excitotoxicity, decreases of NMDA receptor function (disappearance of Ab recognition sites on the cell surface) in correlation with advancing age of the rats subjected to Ab (1±42) lesions may account for the reduced cholinotoxic potential of Ab (1±42) in our model. These data are in contrast with those of Geula et al. (1998) who demonstrated age-related enhancement of Ab toxicity in one monkey brain. Although a ready explanation for such discrepancies is not yet clear, we hypothesize that age-associated changes (i) in cell membrane structure, (ii) in NMDA receptor subunit composition and function, or (iii) in feedback-regulating signal transduction pathways may account for the differences between the vulnerability of the animal species examined. However, we believe that Ab toxicity is not necessarily related to the advanced age of the subject and to the existence of preformed Ab deposits in the brain (Lambert et al., 1998) , but rather to transient changes in Ab production during adulthood that continuously threatens vulnerable regions of the brain.
Our experimental data provide evidence on the tentative neurotoxic mechanism of Ab peptides on cholinergic neurons of the rat MBN that we used here as a well-de®ned in vivo model. We assume that the present phenomenon may account for Ab toxicity in other brain regions as well, including basal forebrain nuclei, hippocampus and cerebral cortex. However, several criteria must be considered before extrapolating our data to other forebrain structures. Firstly, low concentrations of Ab may effectively modulate cholinergic neurotransmission (Abe et al., 1994; Kar et al., 1996; Auld et al., 1998) . Cholinergic neurons of the rat basal forebrain are devoid of Ca 2+ -binding`buffer' proteins, such as calbindin-D28k and parvalbumin (Geula et al., 1993; Van der Zee & Luiten, 1994) , which have been shown to be excito-protective by attenuating the intracellular Ca 2+ overload (Mattson et al., 1991; Harkany et al., 1995a) . Secondly, Kuner et al. (1998) reported that Ab directly binds p75 NTR and thereby initiates a neurotoxic cascade through subsequent activation of nuclear factor kB. In fact, basal forebrain cholinergic neurons are endowed with p75 NTR (Ha Èrtig et al., 1998; Heckers et al., 1994 ) that may render these cells particularly sensitive to Ab toxicity.
It is postulated that g-secretase processing of APP in neurons and glial cells in response to deleterious stimuli (Checler, 1995; Yan et al., 1996) leads to enhanced extracellular accumulation of fulllength Ab in the close vicinity of the activated neural cell. It is concluded from the present data that Ab is then thought to perturb the microhomeostasis-regulating function of glial cells, by the induction of membrane depolarization, which involves the arrest of glial glutamate uptake (Harris et al., 1996) . Simultaneously, Ab probably attacks neurons indirectly via the gradual extracellular accumulation of extracellular glutamate, or directly by the modulation of neurotransmitter receptor function, like that of cholinergic receptors (Kar et al., 1996; Auld et al., 1998) , the NMDA receptor channel (Cowburn et al., 1997) and p75 NTR (Kuner et al., 1998) , and direct association with cell membranes (Arispe et al., 1996) . Irrespective of the actual mechanism of signal transduction, a sustained Ca 2+ overload occurs intracellularly (Mattson et al., 1992; Laskay et al., 1997) that may be a pivotal trigger of cell death. Additionally, overt elevation of [Ca 2+ ] i leads to mitochondrial dysfunction and to the subsequent failure of mitochondrial terminal oxidation resulting in the enhanced formation of ROS (Behl et al., 1994; Pike et al., 1993 Pike et al., , 1997 . Finally, Ca 2+ and ROS may in concert execute cell death (Lafon-Cazal et al., 1993; Suo et al., 1997; Harkany et al. 2000) and predispose nerve cells to degeneration. Although a ®rm link between increased [Ca 2+ ] i and ROS generation was established (Lafon-Cazal et al., 1993; Suo et al., 1997) , the real-time consequences of Ab toxicity on these mechanisms are still to be understood. In this respect, our interpretation of the present data supports a role of NMDA receptor-mediated Ca 2+ entry as a primary postsynaptic event of Ab (1±42) toxicity in vivo. However, based on the fact that ROS Mechanism of b-amyloid toxicity in rat MBN 2743 contribute to the regulation of NMDA receptor function by binding to the redox modulatory site of the receptor (Aizenman et al., 1990) , an early modulatory and/or regulatory role for ROS in the sequence of in vivo Ab (1±42) toxicity cannot be excluded.
The emerging evidence of Ab (1±42) toxicity in vivo supports the concept of Ab as a potent neurotoxin in the brain and its central role in the pathogenesis of AD. Identi®cation of the excitotoxic cascade induced by Ab (1±42) in the MBN may contribute to further understanding of the cellular and molecular mechanisms underlying Ab (1±42) -induced neurodegeneration, and to the development of therapeutic strategies which counteract particular steps of Ab excitotoxicity.
